Eye drop trial offers hope for droopy eyelid after facial paralysis

This study tested whether an FDA-approved eye drop (oxymetazoline) could help lift a drooping eyelid in people with a specific condition that develops after facial paralysis. The condition causes abnormal, tight muscle movements around the eye, leading to a droopy eyelid that can block vision and affect appearance. Researchers enrolled 36 adults to see if using the eye drop alongside their standard treatments improved eyelid position, facial movement, and quality of life.